Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in…
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
This activity is designed for all cardiovascular physicians and cardiac sonographers with arest and knowledge base in the field of echocardiography and reschers, clinicians, intensivists, and other medical professionals with a spein cardiac ultrasound will find this activity beneficial.
Recommendations for chamber quantification.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure and decreased the symptoms and physical limitations of heart failure.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
- J. McMurray, S. Solomon, Modele O Ogunniyi
- MedicineThe New England journal of medicine
- 19 September 2019
Among patients with heart failure and a reduced ejection fraction, the risk of worsening heart failure or death from cardiovascular causes was lower among those who received dapagliflozin than amongThose who received placebo, regardless of the presence or absence of diabetes.
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- M. Vaduganathan, O. Vardeny, T. Michel, J. McMurray, M. Pfeffer, S. Solomon
- Medicine, BiologyThe New England journal of medicine
- 30 March 2020
RAAS Inhibitors in Patients with Covid-19 show low levels of renin–angiotensin-converting enzyme 2 levels and activity in humans, but the effects are still uncertain.
Cardiac-resynchronization therapy for the prevention of heart-failure events.
CRT combined with ICD decreased the risk of heart-failure events in relatively asymptomatic patients with a low ejection fraction and wide QRS complex and was associated with a significant reduction in left ventricular volumes and improvement in the ejectedion fraction.
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Valsartan is as effective as captopril in patients who are at high risk for cardiovascular events after myocardial infarction and the combination of the two on mortality in this population of patients.
Strategies for multivessel revascularization in patients with diabetes.
For patients with diabetes and advanced coronary artery disease, CABG was superior to PCI in that it significantly reduced rates of death and myocardial infarction, with a higher rate of stroke.
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Even mild renal disease, as assessed by the estimated GFR, should be considered a major risk factor for cardiovascular complications after a myocardial infarction.